• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags CDMO platform

CDMO platform News

Business

Suven Pharmaceuticals and Cohance Lifesciences Merge to Forge a Future-Ready CDMO Giant

Ryan Peterson 29 Mar, 2025

The National Company Law Tribunal has approved the merger of Suven Pharmaceuticals and Cohance Lifesciences, aiming to create a diversified CDMO platform focused on high-growth are...

Popular News

  • Market

    Mixed European Markets: GDP Dips, Trade Surplus, ECB Rate Cut

    13 Dec, 2024
  • Market

    Cryptocurrency Market Plummets: Bitcoin Dives Below $77,500 Amidst Widespread Losses

    11 Mar, 2025
  • Business

    MicroStrategy Expands Its Bitcoin Treasury with a $742.4 Million Investment

    11 Feb, 2025
  • Business

    India's Ambitious Plan: Revising Nuclear Liability Laws to Attract Private Investments for a 100 GW Nuclear Energy Goal by 2047

    02 Feb, 2025
  • Business

    Major Investments in Madhya Pradesh: Adani, Reliance, and NTPC Lead with Rs 4 Lakh Crore Pledge

    24 Mar, 2025
  • Business

    US Tariffs Threaten Indian Auto Component Exporters with Up to Rs 4,500 Crore Loss, ICRA Warns

    28 Apr, 2025
  • Market

    European Markets Rally as US Tariff Negotiation Hopes Spark Investor Optimism

    09 Apr, 2025
  • Business

    India and US Set to Finalize Groundbreaking Trade Pact with Sector-Specific Talks in Coming Weeks

    30 Mar, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.